Benzinga · Jul 20, 2026
V2X To Replace Avanos Medical In The S&P SmallCap 600 Effective Prior To The Opening Of Trading On Monday, July 27
https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20260720-1484359/1484359_tmhc-avns-46.pdf
NYSE · AVNS
Avanos Medical, Inc.
Healthcare · Medical - Devices
$24.99
Up+$0.01 (+0.04%)
Updated Oct 8, 2026, 7:11 AM
SID Score
6.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 549.29M
- P/E ratio
- -1.17
- Dividend yield
- 0.00%
- 52-week range
- $9.30 – $25.49
- Volume
- 2.08M
- Avg. volume
- 547.53K
Price performance · AVNS
AVNS price history
1M range · 0 trading sessions · Daily adjusted prices
AVNS does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest AVNS news
The latest Smart Investors Daily articles mentioning AVNS.
Stock researchCompany · Overview
Company
Market Activity
Research & News
AVNS research
Overview
Company profile and research snapshot.
Company profile
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $23.00
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| May 7, 2024 | JMP Securities | Market Perform | — |
| Jul 25, 2023 | Keybanc | Sector Weight | — |
| Jun 21, 2023 | Stifel | Hold | — |
| May 22, 2023 | CL King | Buy | — |
| May 4, 2023 | Morgan Stanley | Underweight | — |
News briefing
No generated briefing is available yet.
Benzinga · Jul 2, 2026
Avanos Medical And American Industrial Partners Obtain Required Regulatory Approvals For Pending Merger
Avanos Medical, Inc. (NYSE:AVNS) ("Avanos") and American Industrial Partners ("AIP") jointly announced the receipt of all required regulatory approvals to complete the pending acquisition of Avanos by
Yahoo · Feb 9, 2026
Waters (WAT) Beats Q4 Earnings and Revenue Estimates
Waters (WAT) delivered earnings and revenue surprises of +0.74% and +0.55%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Yahoo · Feb 4, 2026
Ensign Group (ENSG) Q4 Earnings Surpass Estimates
Ensign Group (ENSG) delivered earnings and revenue surprises of +4.00% and -0.53%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
